{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:58:20Z","timestamp":1793051900482,"version":"4.5.0"},"reference-count":97,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Primary hyperparathyroidism (PHPT) is the most common cause of hypercalcemia in the outpatient setting. Symptomatic presentation includes non-specific signs and symptoms of hypercalcemia, skeletal fragility, nephrolithiasis and nephrocalcinosis. The majority of individuals present at an asymptomatic stage following routine biochemical screening, without any signs or symptoms of calcium or parathyroid hormone (PTH) excess or target organ damage. Indications for surgery have recently been revised as published in recent guidelines and consensus statements. Parathyroidectomy is advised in patients younger than 50 years old and in the presence of either significant hypercalcemia, impaired renal function, renal stones or osteoporosis. Surgery is always appropriate in suitable surgical candidates, however, medical management may be considered in those with mild asymptomatic disease, contraindications to surgery or failed previous surgical intervention. We summarized the optimal medical interventions available in the care of PHPT patients not undergoing parathyroidectomy. Calcium and vitamin D intake should be optimized. Antiresorptive therapy may be used for skeletal protection in patients with an increased fracture risk. Cinacalcet, a calcimimetic agent, has been shown to effectively lower serum calcium and PTH levels. The effect of medical treatment on the reduction in fracture risk is unknown and should be the focus of future research.<\/jats:p>","DOI":"10.3390\/jcm10081604","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T03:04:06Z","timestamp":1618196646000},"page":"1604","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Primary Hyperparathyroidism: A Narrative Review of Diagnosis and Medical Management"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1759-8419","authenticated-orcid":false,"given":"Karel","family":"Dandurand","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, McMaster University, Hamilton, ON L8S 4L8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5378-5548","authenticated-orcid":false,"given":"Dalal S.","family":"Ali","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, McMaster University, Hamilton, ON L8S 4L8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya A.","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, McMaster University, Hamilton, ON L8S 4L8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: Review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.surg.2013.06.051","article-title":"The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: A population-based analysis from the electronic medical record","volume":"154","author":"Press","year":"2013","journal-title":"Surgery"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.amjmed.2010.12.028","article-title":"Outpatient management of primary hyperparathyroidism","volume":"124","author":"Padmanabhan","year":"2011","journal-title":"Am. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","article-title":"Classical complications of primary hyperparathyroidism","volume":"32","author":"Minisola","year":"2018","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: Proceedings of the fourth international workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e1013","DOI":"10.1136\/bmj.e1013","article-title":"Diagnosis and management of primary hyperparathyroidism","volume":"344","author":"Pallan","year":"2012","journal-title":"BMJ"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the fourth international workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","first-page":"184","article-title":"Primary hyperparathyroidism: Pathophysiology and impact on bone","volume":"163","author":"Khan","year":"2000","journal-title":"Can. Med. Assoc. J."},{"key":"ref_9","unstructured":"Bilezikian, J.P., Levine, M.A., Marcocci, C., Silverberg, S.J., and Potts, J.T. (2014). Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. The Parathyroids: Basic and Clinical Concepts, Academic Press."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ali, D., Dandurand, K., and Khan, A. (2021). Atypical presentation of familial hypocalciuric hypercalcemia: Case report. Endocr. Abstr., 59.","DOI":"10.1210\/jendso\/bvab048.369"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4158\/EP11022.OR","article-title":"Low urine calcium excretion in African American patients with primary hyperparathyroidism","volume":"17","author":"Taha","year":"2011","journal-title":"Endocr. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: An update on the changing epidemiology of the disease","volume":"21","author":"Wermers","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the fourth international workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","unstructured":"Bilezikian, J.P., Levine, M.A., Marcocci, C., Silverberg, S.J., and Potts, J.T.J. (2014). Familial and hereditary forms of primary hyperpathyroidism. The Parathyroids: Basic and Clinical Concepts, Elsevier Science and Technology."},{"key":"ref_16","first-page":"98","article-title":"Bone densitometry in asymptomatic primary hyperparathyroidism","volume":"17","author":"Miller","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4158\/EP.6.5.385","article-title":"Skeletal Effects of Primary Hyperparathyroidism","volume":"6","author":"Syed","year":"2000","journal-title":"Endocr. Pract."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2013.03.009","article-title":"New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone","volume":"55","author":"Vu","year":"2013","journal-title":"Bone"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1210\/jc.2012-4255","article-title":"Trabecular bone score (TBS)\u2014A novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism","volume":"98","author":"Silva","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/jbmr.499","article-title":"Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study","volume":"26","author":"Hans","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00268-002-6589-9","article-title":"Fractures in patients with primary hyperparathyroidism: Nationwide follow-up study of 1201 patients","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: A population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","article-title":"Increased mortality and morbidity in mild primary hyperparathyroid patients","volume":"73","author":"Yu","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jbmr.1540","article-title":"Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: A one-year prospective controlled study using high-resolution peripheral quantitative computed tomography","volume":"27","author":"Hansen","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The Natural History of Primary Hyperparathyroidism with or without Parathyroid Surgery after 15 Years","volume":"93","author":"Rubin","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: A prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: A prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/jbmr.3177","article-title":"Effect of surgery versus observation: Skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH Study)","volume":"32","author":"Lundstam","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/jc.2014-3441","article-title":"Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism","volume":"100","author":"Lundstam","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_31","unstructured":"Bilezikian, J.P., Levine, M.A., Marcocci, C., Silverberg, S.J., and Potts, J.T.J. (2014). Clinical presentation of primary hyperparathyroidism, A global perspective. The Parathyroids: Basic and Clinical Concepts, Elsevier Science and Technology."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology","volume":"100","author":"Cipriani","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/2230-8210.93745","article-title":"Renal manifestations of primary hyperparathyroidism","volume":"16","author":"Lila","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/bmj.325.7368.807","article-title":"Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: Controlled retrospective follow up study","volume":"325","author":"Mollerup","year":"2002","journal-title":"BMJ"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4158\/EP14537.OR","article-title":"KDIGO categories of glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism","volume":"21","author":"Tassone","year":"2015","journal-title":"Endocr. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1210\/jc.2006-0070","article-title":"A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism","volume":"91","author":"Gianotti","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1210\/jc.2015-2132","article-title":"Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism","volume":"100","author":"Tassone","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1530\/EJE-12-0032","article-title":"Renal stones and calcifications in patients with primary hyperparathyroidism: Associations with biochemical variables","volume":"166","author":"Waldhauer","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1530\/EJE-16-0430","article-title":"Mechanisms in endocrinology: Kidney involvement in patients with primary hyperparathyroidism: An update on clinical and molecular aspects","volume":"176","author":"Verdelli","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_40","first-page":"87","article-title":"Primary hyperparathyroidism and the kidney: Biochemical and clinical spectrum","volume":"17","author":"Peacock","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00268-003-7046-0","article-title":"Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977\u20131993 in Denmark","volume":"28","author":"Ogard","year":"2004","journal-title":"World J. Surg."},{"key":"ref_42","first-page":"2149","article-title":"Serum calcium and survival in a large health screening program","volume":"81","author":"Leifsson","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_43","first-page":"13","article-title":"Causes of death in patients previously operated on for primary hyperparathyroidism","volume":"74","year":"1985","journal-title":"Ann. Chir. Gynaecol."},{"key":"ref_44","first-page":"3969","article-title":"Arterial blood pressure, serum calcium and PTH in elderly men with parathyroid tumors and primary hyperparathyroidism","volume":"31","author":"Lumachi","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2265.2010.03909.x","article-title":"Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism","volume":"74","author":"Persson","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00259-010-1599-6","article-title":"Reduced coronary flow reserve in patients with primary hyperparathyroidism: A study by G-SPECT myocardial perfusion imaging","volume":"37","author":"Marini","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.111.081307","article-title":"Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy","volume":"126","author":"Osto","year":"2012","journal-title":"Circulation"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jc.2011-2107","article-title":"Aortic valve calcification in mild primary hyperparathyroidism","volume":"97","author":"Iwata","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2004-1400","article-title":"Arterial stiffness in mild primary hyperparathyroidism","volume":"90","author":"Rubin","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1210\/jc.2009-1086","article-title":"Carotid vascular abnormalities in primary hyperparathyroidism","volume":"94","author":"Walker","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2011-1486","article-title":"Depression in primary hyperparathyroidism: Prevalence and benefit of surgery","volume":"96","author":"Espiritu","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.surg.2009.09.034","article-title":"Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with \u201casymptomatic\u201d primary hyperparathyroidism","volume":"146","author":"Perrier","year":"2009","journal-title":"Surgery"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","article-title":"Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: Long-term outcome of a more virulent form of HPT","volume":"247","author":"Norton","year":"2008","journal-title":"Ann. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.3748\/wjg.v17.i36.4063","article-title":"Digestive manifestations of parathyroid disorders","volume":"17","author":"Abboud","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0026-0495(73)90264-3","article-title":"Thiazide diuretics and calcium metabolism","volume":"22","author":"Middler","year":"1973","journal-title":"Metabolism"},{"key":"ref_56","unstructured":"Shlomo, M., Koening, R., Rosen, C., Auchus, R., and Goldfine, A. (2019). Williams Textbook of Endocrinology, Elsevier Health Sciences. [14th ed.]."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e6390","DOI":"10.1136\/bmj.e6390","article-title":"Calcium intake and risk of primary hyperparathyroidism in women: Prospective cohort study","volume":"345","author":"Paik","year":"2012","journal-title":"BMJ"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00394-002-0383-1","article-title":"The effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake","volume":"41","author":"Jorde","year":"2002","journal-title":"Eur. J. Nutr."},{"key":"ref_59","unstructured":"Ross, A.C., Yaktine, A.L., and Del Valle, H.B. (2011). Reference Intakes for Calcium and Vitamin D, The National Academic Press."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF03344140","article-title":"A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism","volume":"29","author":"Boudou","year":"2006","journal-title":"J. Endocrinol. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2265.2005.02371.x","article-title":"Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism","volume":"63","author":"Moosgaard","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2265.1992.tb02278.x","article-title":"The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency","volume":"37","author":"Clements","year":"1992","journal-title":"Clin. Endocrinol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/cs0730659","article-title":"Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism","volume":"73","author":"Clements","year":"1987","journal-title":"Clin. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12020-016-0931-8","article-title":"Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism","volume":"55","author":"Viccica","year":"2016","journal-title":"Endocrine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bone.2010.10.004","article-title":"Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism","volume":"48","author":"Stein","year":"2011","journal-title":"Bone"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2265.2007.03109.x","article-title":"Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism","volume":"68","author":"Moosgaard","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s00268-009-0377-8","article-title":"Vitamin D3 deficiency is associated with late-onset hypocalcemia after minimally invasive parathyroidectomy in a Vitamin D borderline area","volume":"34","author":"Lang","year":"2010","journal-title":"World J. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.1038\/s41598-020-66889-8","article-title":"preoperative Vitamin D levels as a predictor of transient hypocalcemia and hypoparathyroidism after parathyroidectomy","volume":"10","author":"Unsal","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.surg.2005.09.018","article-title":"25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy","volume":"138","author":"Stewart","year":"2005","journal-title":"Surgery"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Salman, M.A., Rabiee, A., Salman, A., Youssef, A., Shaaban, H.E.-D., Ftohy, T.E., Maurice, K.K., and Balamoun, H. (2020). Role of Vitamin D supplements in prevention of hungry bone syndrome after successful parathyroidectomy for primary hyperparathyroidism: A prospective study. Scand. J. Surg.","DOI":"10.1177\/1457496920962601"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/cen.12398","article-title":"Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: A meta-analysis and review of literature","volume":"80","author":"Shah","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","article-title":"Vitamin D treatment in primary hyperparathyroidism: A randomized placebo controlled trial","volume":"99","author":"Rolighed","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: Proceedings of the fourth international workshop on the management of asymptomatic primary hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial","volume":"125","author":"Grey","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1001\/archinte.160.14.2161","article-title":"Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: Four-year follow-up and comparison with healthy postmenopausal women","volume":"160","author":"Evans","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1359\/jbmr.2001.16.1.189","article-title":"Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism","volume":"16","author":"Zanchetta","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"ref_77","first-page":"1076","article-title":"Comparison of alendronate and raloxifene for the management of primary hyperparathyroidism","volume":"36","author":"Akbaba","year":"2013","journal-title":"J. Endocrinol. Investig."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Rubin","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fendo.2017.00079","article-title":"Contemporary medical management of primary hyperparathyroidism: A systematic review","volume":"8","author":"Leere","year":"2017","journal-title":"Front. Endocrinol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: A double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_81","first-page":"1067","article-title":"Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate","volume":"77","author":"Reasner","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00774-013-0473-6","article-title":"Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism","volume":"32","author":"Tournis","year":"2014","journal-title":"J. Bone Miner. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2009-2384","article-title":"Skeletal effects of interventions in mild primary hyperparathyroidism: A meta-analysis","volume":"95","author":"Sankaran","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jgs.15250","article-title":"Protective effect of denosumab on bone in older women with primary hyperparathyroidism","volume":"66","author":"Palmieri","year":"2018","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S2213-8587(20)30063-2","article-title":"Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Leere","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s12020-020-02401-6","article-title":"Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism","volume":"69","author":"Miyaoka","year":"2020","journal-title":"Endocrine"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/EJE-14-0877","article-title":"Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery","volume":"172","author":"Khan","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1530\/EC-20-0221","article-title":"Cinacalcet and primary hyperparathyroidism: Systematic review and meta regression","volume":"9","author":"Ng","year":"2020","journal-title":"Endocr. Connect."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: Biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1210\/jc.2008-2640","article-title":"Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism","volume":"94","author":"Marcocci","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Rostoker, G., Bellamy, J., and Janklewicz, P. (2011). Cinacalcet to prevent parathyrotoxic crises in hypercalcaemic patients awaiting parathyroidectomy. BMJ Case Rep., 2011.","DOI":"10.1136\/bcr.12.2010.3663"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1359\/jbmr.081018","article-title":"Parathyroid carcinoma","volume":"23","author":"Marcocci","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma","volume":"92","author":"Silverberg","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/SLA.0b013e31824c5252","article-title":"Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: Retrospective chart analysis of a prospective database","volume":"255","author":"Keutgen","year":"2012","journal-title":"Ann. Surg."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-011-9459-0","article-title":"Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism","volume":"39","author":"Faggiano","year":"2011","journal-title":"Endocrine"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","article-title":"Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism","volume":"321","author":"Vestergaard","year":"2000","journal-title":"BMJ"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/8\/1604\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:59:17Z","timestamp":1760363957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/8\/1604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":97,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["jcm10081604"],"URL":"https:\/\/doi.org\/10.3390\/jcm10081604","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]}}}